These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 19145073)

  • 81. The combination of lovastatin and enalapril in a model of progressive renal disease.
    Brouhard BH; Takamori H; Satoh S; Inman S; Cressman M; Irwin K; Berkley V; Stowe N
    Pediatr Nephrol; 1994 Aug; 8(4):436-40. PubMed ID: 7947034
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Suppressive effect of an oral sorbent on the accumulation of p-cresol in the serum of experimental uremic rats.
    Niwa T; Ise M; Miyazaki T; Meada K
    Nephron; 1993; 65(1):82-7. PubMed ID: 8413797
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Reduced nephrotoxicity and hepatoxicity in cyclosporin A therapy by enalapril and spironolactone in rats.
    Iacona A; Rossetti A; Filingeri V; Orsini D; Cesarini A; Cervelli V; Adorno D; Casciani CU
    Drugs Exp Clin Res; 1991; 17(10-11):501-6. PubMed ID: 1841039
    [TBL] [Abstract][Full Text] [Related]  

  • 84. [Pharmacologic portrait of enalapril].
    Rahn KH
    Fortschr Med Suppl; 1988; 52():4-5. PubMed ID: 2905335
    [No Abstract]   [Full Text] [Related]  

  • 85. Sevelamer: a promising but unproven drug.
    Palmer SC; Craig JC; Strippoli GF
    Nephrol Dial Transplant; 2007 Oct; 22(10):2742-5. PubMed ID: 17906325
    [No Abstract]   [Full Text] [Related]  

  • 86. Uraemic arterial disease. An experimental study with special reference to the effect of parathyroidectomy.
    Ejerblad S; Eriksson I; Johansson H
    Scand J Urol Nephrol; 1979; 13(2):161-9. PubMed ID: 482867
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Left ventricular function and response to enalapril in patients with Duchenne muscular dystrophy during the second decade of life.
    Giglio V
    Am J Cardiol; 2007 Jan; 99(1):147-8. PubMed ID: 17196482
    [No Abstract]   [Full Text] [Related]  

  • 88. After several years of witchhunting, can calcium-based phosphate binding be released on probation?
    Ketteler M; Biggar P
    Nephrol Dial Transplant; 2008 Jan; 23(1):17-9. PubMed ID: 18039641
    [No Abstract]   [Full Text] [Related]  

  • 89. Experimental normocalcaemic hyperparathyroidism induced by renal venous congestion.
    Du Rietz B; Ekman R; Olin T; Olsson AM
    Urol Res; 1977; 5(3):109-12. PubMed ID: 919110
    [TBL] [Abstract][Full Text] [Related]  

  • 90. [Calcifying uremic arteriopathy].
    Janda J
    Cesk Patol; 1986 May; 22(2):103-7. PubMed ID: 3731292
    [TBL] [Abstract][Full Text] [Related]  

  • 91. A 14-year-old girl with renal abnormalities after brief intrauterine exposure to enalapril during late gestation.
    Guron G; Mölne J; Swerkersson S; Friberg P; Hansson S
    Nephrol Dial Transplant; 2006 Feb; 21(2):522-5. PubMed ID: 16311256
    [No Abstract]   [Full Text] [Related]  

  • 92. Influence of vasoactive substances on uremic bleeding in rats.
    Sprott H; Fleck C; Bräunlich H
    Exp Pathol; 1991; 42(2):115-20. PubMed ID: 1879514
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Does sevelamer have greater skeletal benefit than calcium carbonate in children with secondary hyperparathyroidism?
    Akizawa T
    Nat Clin Pract Nephrol; 2006 Mar; 2(3):130-1. PubMed ID: 16932409
    [No Abstract]   [Full Text] [Related]  

  • 94. Gastric mucosal calcinosis: clinicopathologic considerations.
    Gorospe M; Fadare O
    Adv Anat Pathol; 2007 May; 14(3):224-8. PubMed ID: 17452819
    [TBL] [Abstract][Full Text] [Related]  

  • 95. The vascular renin-angiotensin system as a possible source of vascular inflammation in fructose-fed rats.
    Ishibashi S
    Hypertens Res; 2007 May; 30(5):375-6. PubMed ID: 17587748
    [No Abstract]   [Full Text] [Related]  

  • 96. Corticosterone: a catabolic factor in uremic rats with chronic acidosis?
    Lasserre JJ; Strauch M; Gretz N
    Contrib Nephrol; 1990; 81():154-60. PubMed ID: 2093491
    [No Abstract]   [Full Text] [Related]  

  • 97. Calcareous degeneration of the eye--an unusual complication of uraemic hyperparathyroidism.
    Tarrass F; Benjelloun M; Benghanem MG; Ramdani B
    Nephrol Dial Transplant; 2006 Nov; 21(11):3330. PubMed ID: 16891643
    [No Abstract]   [Full Text] [Related]  

  • 98. Beyond phosphate--role of uraemic toxins in cardiovascular calcification.
    Nikolov I; Joki N; Drüeke T; Massy Z
    Nephrol Dial Transplant; 2006 Dec; 21(12):3354-7. PubMed ID: 17005531
    [No Abstract]   [Full Text] [Related]  

  • 99. Blood pressure and uremic cardiomyopathy.
    Rambausek M; Kollmar S; Mall G; Ritz E
    Contrib Nephrol; 1988; 60():230-5. PubMed ID: 3278857
    [No Abstract]   [Full Text] [Related]  

  • 100. [Pancytopenia as adverse event due to enalapril and glipizide on renal failure].
    Ocaña J; Torres M; Gómez Navarro L; Chevarría JL
    Nefrologia; 2007; 27(5):655-6. PubMed ID: 18045051
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.